Stockscreener 앱 받기
0.96
0.52%
-0.005
전일 마감가:
$0.965
열려 있는:
$0.9476
하루 거래량:
1.31M
Relative Volume:
0.71
시가총액:
$374.47M
수익:
$105.90M
순이익/손실:
$-61.49M
주가수익비율:
-4.8682
EPS:
-0.1972
순현금흐름:
$-82.65M
1주 성능:
+3.17%
1개월 성능:
-16.52%
6개월 성능:
-31.43%
1년 성능:
-18.64%
1일 변동 폭
$0.9418
$0.97
1주일 범위
$0.9242
$1.00
52주 변동 폭
$0.92
$1.72
Standard Biotools Inc Stock (LAB) Company Profile
명칭
Standard Biotools Inc
전화
(650) 266-6000
주소
50 MILK STREET, BOSTON
Compare LAB vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
0.96 | 374.47M | 105.90M | -61.49M | -82.65M | -0.1972 |
ABT
Abbott Laboratories
|
107.19 | 186.26B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
339.76 | 130.02B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.87 | 111.53B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.89 | 103.71B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.46 | 47.89B | 6.07B | 1.06B | 1.34B | 1.8063 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-13 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-02-27 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-04-16 | 개시 | TD Cowen | Buy |
| 2024-04-04 | 개시 | Jefferies | Buy |
| 2023-07-12 | 개시 | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc 주식(LAB)의 최신 뉴스
Whale Trades: Can Standard BioTools Inc stock double in the next yearGDP Growth & Safe Entry Momentum Tips - baoquankhu1.vn
Long Focus Capital Management LLC Acquires 1,292,804 Shares of Standard BioTools Inc. $LAB - MarketBeat
Standard BioTools Inc. $LAB Shares Purchased by Mak Capital One LLC - MarketBeat
Standard BioTools Inc. 2025 Annual Report: Market Overview, Innovation, and Regulatory Landscape in Life Sciences Tools - Minichart
Standard BioTools 2025 10-K: Revenue $85.3M, EPS $(0.20) - TradingView
Standard BioTools (NASDAQ: LAB) refocuses on core tools after SomaScan sale - Stock Titan
Standard BioTools Inc. $LAB Stake Boosted by Casdin Capital LLC - MarketBeat
Shorts Report: Can Standard BioTools Inc grow without dilution2026 Trading Recap & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Standard BioTools (NASDAQ:LAB) Cut to "Sell" at Wall Street Zen - MarketBeat
Retail Trends: Will Standard BioTools Inc stock hit new highs in YEARWeekly Market Report & Fast Momentum Entry Tips - baoquankhu1.vn
Does Standard BioTools Inc have declining or rising EPSJuly 2025 Chart Watch & Fast Momentum Entry Tips - baoquankhu1.vn
Aug PostEarnings: Should I invest in Standard BioTools Inc before earningsQuarterly Trade Summary & Expert Verified Movement Alerts - baoquankhu1.vn
LAB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
LAB Technical Analysis & ETF Price Forecast - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
Eli Casdin boosts equity stake in STANDARD BIOTOOLS (LAB) with 52,991 RSUs - Stock Titan
STANDARD BIOTOOLS (LAB) director takes 51,282 RSUs in lieu of $60K cash - Stock Titan
Retail Trends: Is Standard BioTools Inc a strong growth stockJuly 2025 Analyst Calls & Weekly High Return Opportunities - baoquankhu1.vn
Director at Standard BioTools (LAB) takes RSUs instead of cash pay - Stock Titan
Standard BioTools (NASDAQ:LAB) Upgraded to Hold at Wall Street Zen - MarketBeat
Standard BioTools Inc. (LAB) Stock Analysis: Unveiling a 32% Upside Potential Amidst Challenging Metrics - DirectorsTalk Interviews
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Globus Medical (GMED), Standard BioTools (LAB) and Addus Homecare (ADUS) - The Globe and Mail
Standard BioTools (LAB) Q4 Profit Challenges Longstanding Unprofitable Narrative - Sahm
Standard BioTools Q4 2025 Results: Profit on $23.8M RevenueNews and Statistics - IndexBox
Standard BioTools Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Standard BioTools (LAB) Reports Strong Q4 Revenue Exceeding Expe - GuruFocus
Standard BioTools Inc (NASDAQ:LAB) Surges on Strong Q4 Earnings Beat - ChartMill
STANDARD BIOTOOLS (LAB) CEO has shares withheld to cover RSU tax bill - Stock Titan
Standard BioTools (LAB) SVP disposes shares for tax withholding - Stock Titan
Tax withholding trims Standard BioTools (LAB) CFO share stake - Stock Titan
Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results - Investing News Network
Standard Biotools earnings beat by $0.10, revenue topped estimates - Investing.com Canada
Standard BioTools Details SomaLogic Sale and Profitability Path - TipRanks
LAB Forecasts Revenue Between $80 Million and $85 Million for FY - GuruFocus
Standard BioTools: Q4 Earnings Snapshot - marketscreener.com
Standard BioTools (NASDAQ:LAB) Announces Earnings Results - MarketBeat
Standard BioTools Q4 Earnings Report: What Investors Need to Know - Benzinga
Preview: Standard BioTools's Earnings - Benzinga
LABSTANDARD BIOTOOLS INC Latest Stock News & Market Updates - Stock Titan
Standard BioTools Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView
Standard BioTools Inc. (LAB) Stock Analysis: Healthcare Innovator Shows 34.78% Potential Upside - DirectorsTalk Interviews
What hedge fund activity signals for Standard BioTools Inc. stock2025 Geopolitical Influence & Short-Term High Return Ideas - mfd.ru
MSN Money - MSN
Standard BioTools (LAB) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
How Standard BioTools Inc. stock performs during Fed tightening cyclesWeekly Trend Recap & Short-Term Trading Alerts - mfd.ru
Illumina Stock May Benefit From New Agreement to Acquire SomaLogic - MSN
Illumina completes acquisition of SomaLogic from Standard BioTools - BizWest
Standard BioTools Inc. (LAB) Stock Analysis: Unpacking a 39.64% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
LAB PE Ratio & Valuation, Is LAB Overvalued - Intellectia AI
Can Standard BioTools Inc. (FLB) stock survive global slowdownFed Meeting & Weekly Setup with ROI Potential - mfd.ru
Standard BioTools Inc.'s (NASDAQ:LAB) Popularity With Investors Under Threat As Stock Sinks 27% - simplywall.st
Standard Biotools Inc (LAB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
1.86%
자본화:
|
볼륨(24시간):